References
- Russo MJ, McCabe JM, Thourani VH, et al. Case volume and outcomes after TAVR with balloon-expandable prostheses. Insights from TVT registry. J Am Coll Cardiol. 2019;73(4):427–440. doi:10.1016/j.jacc.2018.11.031.
- Wood DA, Lauck SB, Cairns JA, et al. The Vancouver 3M (Multidisciplinary, multimodality, but minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: the 3M TAVR study. JACC Cardiovasc Interv. March 11, 2019;12(5):459–469. doi:10.1016/j.jcin.2018.12.020.
- Lu, D. There has been an increase in other causes of deaths, not just Coronavirus.https://www.nytimes.com/interactive/2020/06/01/us/coronavirus-deaths-new-york-new-jersey.html. Assessed June 14, 2020.